Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
371 studies found for:    Open Studies | "Alzheimer Disease"
Show Display Options
Rank Status Study
21 Recruiting Early Counseling and Support for Alzheimer's Disease Caregivers
Condition: Alzheimer's Disease
Interventions: Behavioral: Psychosocial Intervention;   Behavioral: Educational Intervention on AD
22 Recruiting A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: elenbecestat (E2609);   Drug: Placebo
23 Recruiting A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Condition: Alzheimer's Disease
Interventions: Drug: elenbecestat (E2609);   Drug: Placebo
24 Not yet recruiting Enteric Nervous System in Alzheimer Disease
Condition: Alzheimer Disease
Interventions: Procedure: Rectosigmoidoscopy with colonic biopsies;   Procedure: Colonoscopy with colonic biopsies
25 Not yet recruiting S-Equol in Alzheimer's Disease 2 Trial
Condition: Alzheimer Disease
Interventions: Drug: S-equol;   Other: Placebo
26 Recruiting Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Meganatural-Az Grapeseed Extract;   Drug: Placebo
27 Recruiting A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ABBV-8E12;   Drug: placebo for ABBV-8E12
28 Recruiting Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ALZT-OP1a;   Drug: ALZT-OP1b;   Other: Placebo ALZT-OP1a;   Other: Placebo ALZT-OP1b
29 Recruiting Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Use of rTMS
Condition: Alzheimer's Disease
Interventions: Procedure: Repetitive Transcranial Magnetic Stimulation;   Procedure: Repetitive Transcranial Magnetic Stimulation - Sham
30 Recruiting Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: human umbilical cord blood derived mesenchymal stem cells;   Other: Normal saline 2mL
31 Recruiting Imaging Tau in Alzheimer's Disease and Normal Aging
Condition: Alzheimer's Disease
Interventions: Drug: 18F-THK- 5351;   Procedure: Lumbar Puncture (optional)
32 Recruiting Biomarker Study for Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Other: Blood sample
33 Recruiting Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Procedure: Liposuction under local anesthesia;   Biological: Infusion of AD-SVF via IV and Intranasal
34 Recruiting Behavioral Expressions in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Acetaminophen;   Other: Placebo
35 Recruiting An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
Condition: Alzheimer´s Disease
Interventions: Drug: Lanabecestat;   Drug: Placebo
36 Recruiting Evaluating Liraglutide in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Liraglutide;   Drug: Placebo
37 Recruiting Alzheimer's Disease and Physiological, Cognitive Function and BDNF Levels of Plasma Adaptation After Exercise Training
Condition: Alzheimer's Disease
Interventions: Device: Endurance Training;   Other: therapeutic education meetings
38 Recruiting Monetary Cost of Alzheimer's Disease in China
Condition: Alzheimer's Disease
Intervention: Other: observation
39 Recruiting SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
Condition: Alzheimer's Disease
Interventions: Drug: SUVN-502;   Drug: Placebo
40 Recruiting The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study
Condition: Alzheimer Disease
Interventions: Drug: MLC901;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.